https://www.selleckchem.com/products/grl0617.html
2) A 25G (or higher) needle should be used when injecting into the deepleg compartment muscles. 3) The INR level ≤3.5 should be used when injecting the deep posterior leg compartment muscles. 4) The concern regarding bleeding when using DOACs remain the same as with warfarin when INR is in the therapeutic range. 6) The dose and scheduling of DOACs need not be altered prior to BoNTA injections. CONCLUSIONS The Canadian consensus statements assist clinicians by providing a framework for consideration to navigate the challenges when inject
Like
Comment
Share
